Traders sold shares of DaVita HealthCare Partners Inc. (NYSE:DVA) on strength during trading on Friday. $20.29 million flowed into the stock on the tick-up and $191.26 million flowed out of the stock on the tick-down, for a money net flow of $170.97 million out of the stock. Of all companies tracked, DaVita HealthCare Partners had the highest net out-flow for the day. DaVita HealthCare Partners traded up $0.33 for the day and closed at $77.91

Several research firms have recently issued reports on DVA. Wells Fargo & Co. restated a “buy” rating on shares of DaVita HealthCare Partners in a report on Saturday, June 4th. Robert W. Baird restated a “buy” rating on shares of DaVita HealthCare Partners in a report on Sunday, May 8th. Zacks Investment Research upgraded DaVita HealthCare Partners from a “hold” rating to a “buy” rating and set a $87.00 price objective on the stock in a report on Tuesday, July 5th. TheStreet upgraded DaVita HealthCare Partners from a “hold” rating to a “buy” rating in a report on Wednesday, May 4th. Finally, Jefferies Group restated a “buy” rating on shares of DaVita HealthCare Partners in a report on Monday, April 4th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company’s stock. DaVita HealthCare Partners has an average rating of “Hold” and a consensus target price of $78.88.

The company has a market cap of $16.09 billion and a P/E ratio of 34.95. The company’s 50-day moving average is $76.70 and its 200-day moving average is $72.31.

DaVita HealthCare Partners (NYSE:DVA) last posted its quarterly earnings results on Wednesday, May 4th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.86 by $0.06. During the same period in the prior year, the company posted $0.86 EPS. The company earned $3.58 billion during the quarter, compared to the consensus estimate of $3.51 billion. DaVita HealthCare Partners’s quarterly revenue was up 8.9% on a year-over-year basis. On average, equities research analysts anticipate that DaVita HealthCare Partners Inc. will post $3.95 EPS for the current fiscal year.

In other DaVita HealthCare Partners news, insider Jeanine Marie Jiganti sold 1,291 shares of the business’s stock in a transaction on Monday, July 11th. The shares were sold at an average price of $78.51, for a total transaction of $101,356.41. Following the sale, the insider now directly owns 5,716 shares of the company’s stock, valued at approximately $448,763.16. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Dennis Kogod sold 40,048 shares of the business’s stock in a transaction on Tuesday, May 10th. The shares were sold at an average price of $76.25, for a total transaction of $3,053,660.00. Following the sale, the chief executive officer now directly owns 92,716 shares in the company, valued at $7,069,595. The disclosure for this sale can be found here.

A number of hedge funds have recently made changes to their positions in the stock. Principal Financial Group Inc. increased its stake in shares of DaVita HealthCare Partners by 14.5% in the fourth quarter. Principal Financial Group Inc. now owns 2,365,751 shares of the company’s stock valued at $164,916,000 after buying an additional 299,194 shares during the period. GSA Capital Partners LLP increased its stake in shares of DaVita HealthCare Partners by 198.6% in the fourth quarter. GSA Capital Partners LLP now owns 40,283 shares of the company’s stock valued at $2,808,000 after buying an additional 26,791 shares during the period. Mark Sheptoff Financial Planning LLC increased its stake in shares of DaVita HealthCare Partners by 0.3% in the fourth quarter. Mark Sheptoff Financial Planning LLC now owns 37,937 shares of the company’s stock valued at $2,645,000 after buying an additional 100 shares during the period. Vanguard Group Inc. increased its stake in shares of DaVita HealthCare Partners by 1.0% in the fourth quarter. Vanguard Group Inc. now owns 14,380,779 shares of the company’s stock valued at $1,002,484,000 after buying an additional 137,560 shares during the period. Finally, Pittenger & Anderson Inc. increased its stake in shares of DaVita HealthCare Partners by 93.2% in the fourth quarter. Pittenger & Anderson Inc. now owns 29,360 shares of the company’s stock valued at $2,047,000 after buying an additional 14,160 shares during the period.

DaVita HealthCare Partners Inc is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. Its segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. Its Kidney Care division is a provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.